Array Biopharma, Inc. (ARRY) Posts Q3 Loss of 20c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.00 +4.44%
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -11.6%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Rochon family buys $100M in AIAI Holdings shares at $20 each
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
